High Rates of Clinical and Subclinical Tuberculosis among HIV-Infected Ambulatory Subjects in Tanzania

Mtei, Lillian; Matee, Mecky; Herfort, Oliver; Bakari, Muhammad; Horsburgh, C. Robert; Waddell, Richard; Cole, Bernard F.; Vuola, Jenni M.; Tvaroha, Susan; Kreiswirth, Barry; Pallangyo, Kisali; von Reyn, C. Fordham
May 2005
Clinical Infectious Diseases;5/15/2005, Vol. 40 Issue 10, p1500
Academic Journal
Background. We sought to determine the prevalence of active tuberculosis among ambulatory HIV-infected persons in Tanzania with CD4 cell counts of ⩾200 cells/mm³ and a bacille Calmette-Guérin vaccination scat Methods. Subjects who volunteered for a tuberculosis booster vaccine trial were screened for active tuberculosis by obtainment of a history, physical examination, chest radiography, sputum culture and acid fast bacillus (AFB) stain, and blood culture. All subjects underwent a tuberculin skin test (TST) and lymphocyte proliferation assays (LPAs) for detection of responses to mycobacterial antigens. Results. Active tuberculosis was identified at baseline in 14 (15%) of the first 93 subjects who were enrolled: 10 (71%) had clinical tuberculosis (symptoms or chest radiograph findings), and 4 (29%) had subclinical tuberculosis (positive sputum AFB stain or culture results but no symptoms or chest radiograph findings). An additional 6 subjects with subclinical tuberculosis were identified subsequently. The 10 subjects with subclinical tuberculosis included 3 with positive sputum AFB stains results and 7 who were only identified by a positive sputum culture result. Compared with subjects who did not have tuberculosis, the 10 subjects with subclinical tuberculosis were more likely to have peripheral lymphadenopathy, positive TST results, and elevated LPA responses to early secreted antigenic target-6 (ESAT). Eight of 10 patients had received isoniazid because of a positive TST result before active tuberculosis was recognized. Conclusions. Clinical and subclinical tuberculosis are common among ambulatory HIV-infected persons, and some cases can only be identified by sputum culture. World Health Organization guidelines for screening for latent tuberculosis before treatment do not recommend sputum culture and, therefore, may fail to identify a substantial number of HIV-infected persons with subclinical, active tuberculosis.


Related Articles

  • The Impact of HIV Infection and CD4 Cell Count on the Performance of an Interferon Gamma Release Assay in Patients with Pulmonary Tuberculosis. Aabye, Martine G.; Ravn, Pernille; PrayGod, George; Jeremiah, Kidola; Mugomela, Apolinary; Jepsen, Maria; Faurholt, Daniel; Range, Nyagosya; Friis, Henrik; Changalucha, John; Andersen, Aase B. // PLoS ONE;2009, Vol. 4 Issue 1, p1 

    Background: The performance of the tuberculosis specific Interferon Gamma Release Assays (IGRAs) has not been sufficiently documented in tuberculosis- and HIV-endemic settings. This study evaluated the sensitivity of the QuantiFERON TB-Gold In-Tube (QFT-IT) in patients with culture confirmed...

  • Pulmonary tuberculosis: diagnosis and treatment. Campbell, Ian A.; Bah-Sow, Oumou // BMJ: British Medical Journal (International Edition);5/20/2006, Vol. 332 Issue 7551, p1194 

    The article focuses on the symptoms, diagnosis and treatment of tuberculosis. Diagnostic technologies such as skin testing and chest radiography are discussed, as well as how to deal with drug resistance. The importance of trust to the patient during the chemotherapy process to the success of...

  • What is TB disease?  // Tuberculosis: Getting Healthy, Staying Healthy;Jun2008, Issue 8, p9 

    The article provides an answer to a question of what is the nature of the tuberculosis (TB) disease.

  • How can my doctor tell if I have TB disease?  // Tuberculosis: Getting Healthy, Staying Healthy;Jun2008, Issue 8, p11 

    The article provides an answer to a question of how physicians will determine if the patient has tuberculosis (TB) disease.

  • Characterization of Mycobacterium tuberculosis Central Asian Strain1 using mycobacterial interspersed repetitive unit genotyping. Ali, Asho; Hasan, Zahra; Tanveer, Mahnaz; Siddiqui, Amna R.; Ghebremichael, Solomon; Kallenius, Gunilla; Hasan, Rumina // BMC Microbiology;2007, Vol. 7, p1 

    Background: The Central Asian Strain1 (CAS1) genogroup of Mycobacterium tuberculosis (MTB) is the most prevalent in Pakistan, India and Bangladesh. Mycobacterial interspersed repetitive units variable number tandem repeat (MIRU-VNTR) typing is a reliable and reproducible method for...

  • Genetic Diversity of the Mycobacterium tuberculosis Beijing Family Based on SNP and VNTR Typing Profiles in Asian Countries. Yih-Yuan Chen; Jia-Ru Chang; Wei-Feng Huang; Shu-Chen Kuo; Ih-Jen Su; Jun-Ren Sun; Tzong-Shi Chiueh; Tsi-Shu Huang; Yao-Shen Chen; Horng-Yunn Dou // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    The Mycobacterium tuberculosis (MTB) Beijing strain is highly virulent, drug resistant, and endemic over Asia. To explore the genetic diversity of this family in several different regions of eastern Asia, 338 Beijing strains collected in Taiwan (Republic of China) were analyzed by mycobacterial...

  • Pulmonary Tuberculosis in Extrapulmonary Tuberculosis (XPTB). Deresinski, Stan // Clinical Infectious Diseases;1/1/2009, Vol. 48 Issue 1, preceding p1 

    The article cites a research study conducted to examine the consequences of carrying sputum specimens for microscopic evaluation and culture for HIV-uninfected patients with pulmonary tuberculosis in extrapulmonary tuberculosis (XPTB) who have a normal chest radiograph findings. Researchers have...

  • Apego al tratamiento y el desarrollo de fármacoresistencia. Limitaciones y necesidades para el desarrollo de estrategias para el control efectivo de la tuberculosis. García-García, Ma. de Lourdes // Salud Pública de México;mar/abr2007 suppleme 2, Vol. 49, pE127 

    Tuberculosis was identified as a global problem in 1993 and is the second cause of death produced by a single pathogen. The main obstacles to achieve an adequate control are poor performance of local programs, lack of treatment compliance, appearance of drug-resistant Mycobacterium tuberculosis...

  • Plenary Lectures.  // Annals of Clinical Biochemistry;Jan2006 Supplement, Vol. 43, p1 

    Biosensors in medicine. C Lowe, Cambridge. 1 Molecular therapy for diabetes. L Chan, Houston, USA. 1 C-reactive protein and cardiovascular risk. N Rifai, Boston, USA. 1 The role of gut hormones in obesity and appetite regulation. C le Roux, London. 2 Good and bad for the bone. W D Fraser,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics